acetylcysteine and Ureteral Obstruction

acetylcysteine has been researched along with Ureteral Obstruction in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Honma, S; Sakai, M; Soma, I; Tani, I; Toriyabe, K; Yoshida, M1
Aydın, A; Börcek, P; Karakan, T; Koca, G; Öğüş, E; Sunay, M1
Gan, XX; Lu, LM; Miao, NJ; Shen, Y; Xu, D; Xu, JL; Xue, H; Zhang, W; Zhou, L1
Hamatani, H; Hiromura, K; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakairi, T; Takahashi, S; Takeuchi, S; Tomioka, M1
Andrade, L; Danilovic, A; Libório, AB; Sanches, TR; Seguro, AC; Shimizu, MH; Volpini, RA1
Benderev, TV1
Caponegro, PJ; Leadbetter, GW1

Other Studies

7 other study(ies) available for acetylcysteine and Ureteral Obstruction

ArticleYear
Effect of N-Acetyl Cysteine on Renal Interstitial Fibrosis in Mice.
    Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:12

    Topics: Acetylcysteine; Animals; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Reactive Oxygen Species; Ureteral Obstruction

2020
Do Montelukast Sodium and N-Acetylcysteine Have a Nephroprotective Effect on Unilateral Ureteral Obstruction? A Placebo Controlled Trial in a Rat Model.
    The Journal of urology, 2015, Volume: 194, Issue:4

    Topics: Acetates; Acetylcysteine; Animals; Cyclopropanes; Disease Models, Animal; Kidney Diseases; Male; Placebos; Quinolines; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Sulfides; Ureteral Obstruction

2015
N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:5

    Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cell Line; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Ureteral Obstruction

2016
Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:1

    Topics: Acetylcysteine; Actins; Animals; Cells, Cultured; Cysteine Proteinase Inhibitors; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Kidney Diseases; Leupeptins; Male; Nerve Tissue Proteins; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Smad Proteins, Receptor-Regulated; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta; Ureteral Obstruction

2011
N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10

    Topics: Acetylcysteine; Animals; Aquaporin 2; Glomerular Filtration Rate; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Osmolar Concentration; Rats; Rats, Wistar; Renal Circulation; Thiobarbituric Acid Reactive Substances; Ureteral Obstruction; Urine

2008
Acetylcysteine for urinary tract mucolysis.
    The Journal of urology, 1988, Volume: 139, Issue:2

    Topics: Acetylcysteine; Adult; Humans; Ileum; Male; Mucus; Postoperative Complications; Recurrence; Ureter; Ureteral Obstruction

1988
Acute ureteral obstruction secondary to mucoid impaction in supravesical diversion. Treatment with N-acetylcysteine.
    Urology, 1974, Volume: 3, Issue:4

    Topics: Acetylcysteine; Adult; Colon, Sigmoid; Female; Humans; Hydronephrosis; Ileum; Male; Mucus; Postoperative Complications; Proteins; Radiography; Ureter; Ureteral Obstruction; Urinary Diversion

1974